These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2459035

  • 1. Pharmacokinetic studies with recombinant hirudin in dogs.
    Nowak G, Markwardt F, Fink E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):70-4. PubMed ID: 2459035
    [Abstract] [Full Text] [Related]

  • 2. Studies on the pharmacokinetics of hirudin.
    Markwardt F, Nowak G, Stürzebecher U, Walsmann P.
    Biomed Biochim Acta; 1987; 46(4):237-44. PubMed ID: 3632647
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration.
    Bichler J, Fichtl B, Siebeck M, Fritz H.
    Arzneimittelforschung; 1988 May; 38(5):704-10. PubMed ID: 3415713
    [Abstract] [Full Text] [Related]

  • 5. A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis.
    Schiele F, Vuillemenot A, Kramarz P, Kieffer Y, Soria J, Soria C, Camez A, Mirshahi MC, Bassand JP.
    Thromb Haemost; 1994 May; 71(5):558-62. PubMed ID: 8091380
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics study of recombinant hirudin in the plasma of rats using chromogenic substrate, ELISA, and radioisotope assays.
    Jiang SY, Jiao J, Zhang TT, Xu YP.
    PLoS One; 2013 May; 8(6):e64336. PubMed ID: 23785400
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of 125I-hirudin in rats and dogs.
    Richter M, Cyranka U, Nowak G, Walsmann P.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 May; 115(1-2):64-9. PubMed ID: 2459034
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and anticoagulant effect of hirudin in man.
    Markwardt F, Nowak G, Stürzebecher J, Griessbach U, Walsmann P, Vogel G.
    Thromb Haemost; 1984 Oct 31; 52(2):160-3. PubMed ID: 6523433
    [Abstract] [Full Text] [Related]

  • 9. Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group.
    Verstraete M, Nurmohamed M, Kienast J, Siebeck M, Silling-Engelhardt G, Büller H, Hoet B, Bichler J, Close P.
    J Am Coll Cardiol; 1993 Oct 31; 22(4):1080-8. PubMed ID: 8409044
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamic and safety results of PEG-Hirudin in healthy volunteers.
    Esslinger HU, Haas S, Maurer R, Lassmann A, Dübbers K, Müller-Peltzer H.
    Thromb Haemost; 1997 May 31; 77(5):911-9. PubMed ID: 9184402
    [Abstract] [Full Text] [Related]

  • 11. Pharmacology of recombinant hirudin.
    Nowak G.
    Semin Thromb Hemost; 2002 Oct 31; 28(5):415-24. PubMed ID: 12420236
    [Abstract] [Full Text] [Related]

  • 12. Biological relevance of anti-recombinant hirudin antibodies--results from in vitro and in vivo studies.
    Liebe V, Brückmann M, Fischer KG, Haase KK, Borggrefe M, Huhle G.
    Semin Thromb Hemost; 2002 Oct 31; 28(5):483-90. PubMed ID: 12420244
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological studies on the antithrombotic action of hirudin in experimental animals.
    Markwardt F, Hauptmann J, Nowak G, Klessen C, Walsmann P.
    Thromb Haemost; 1982 Jun 28; 47(3):226-9. PubMed ID: 7112494
    [Abstract] [Full Text] [Related]

  • 14. [The pharmacology of recombinant hirudin].
    Kaiser B.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Jun 28; 116(6):841-9. PubMed ID: 2483701
    [Abstract] [Full Text] [Related]

  • 15. Clinical pharmacology of recombinant hirudin.
    Markwardt F, Nowak G, Stürzebecher J.
    Haemostasis; 1991 Jun 28; 21 Suppl 1():133-6. PubMed ID: 1894188
    [Abstract] [Full Text] [Related]

  • 16. Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective dose-ranging randomized trial. International Multicentre Hirudin Study Group.
    Schiele F, Lindgaerde F, Eriksson H, Bassand JP, Wallmark A, Hansson PO, Grollier G, Sjo M, Moia M, Camez A, Smyth V, Walker M.
    Thromb Haemost; 1997 May 28; 77(5):834-8. PubMed ID: 9184388
    [Abstract] [Full Text] [Related]

  • 17. Pharmacodynamics and pharmacokinetics of recombinant hirudin via four non-parenteral routes.
    Liu Y, Lu WL, Zhang X, Wang XQ, Zhang H, Zhang Q.
    Peptides; 2005 Mar 28; 26(3):423-30. PubMed ID: 15652649
    [Abstract] [Full Text] [Related]

  • 18. [Studies on preparation of recombinant hirudin-2 liposome and its pharmacokinetics by nasal delivery in rats].
    Zhang YJ, Wang XL, Wu JM, Cheng MX.
    Zhongguo Zhong Yao Za Zhi; 2007 May 28; 32(9):801-4. PubMed ID: 17639978
    [Abstract] [Full Text] [Related]

  • 19. Studies on the pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after intravenous and subcutaneous administration in dogs.
    Iyer L, Koza M, Iqbal O, Calabria R, Fareed J.
    Thromb Res; 1993 Feb 01; 69(3):259-69. PubMed ID: 8475476
    [Abstract] [Full Text] [Related]

  • 20. Immunoassays in monitoring biotechnological drugs.
    Gygax D, Botta L, Ehrat M, Graf P, Lefèvre G, Oroszlan P, Pfister C.
    Ther Drug Monit; 1996 Aug 01; 18(4):405-9. PubMed ID: 8857560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.